Navigation Links
Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus
Date:11/6/2009

SPRING VALLEY, Calif., Nov. 6 /PRNewswire/ -- Calbiotech, Inc. announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase I contract by the U.S. Army Medical Research and Material command. Under terms of the agreement, Calbiotech will develop analyte specific reagents (ASRs) for the diagnosis of Dengue virus.

Dengue virus is a mosquito-born flavivirus that represents a major threat to military forces deployed to tropical areas of the world. Due to its worldwide distribution, U.S. military and civilian personnel deployed overseas are at high risk of being infected. The global prevalence of Dengue has grown dramatically in recent decades, spreading from 9 to some 40 countries. The disease is now endemic in more than 100 countries in Africa, the Americas, the Eastern Mediterranean, Southeast Asia and the Western Pacific. Not only is the number of cases increasing as the disease is spreading to new areas, but explosive outbreaks are occurring. In 2007, Venezuela reported over 80 000 cases.

Technology developed under this research project will enable an affordable FDA-approved method for diagnosing Dengue fever in blood/sera. This will enable medical personnel to adequately diagnose and react to Dengue fever outbreaks.

This Phase I award will allow Calbiotech to compete for $730,000 in Phase II funding. A Phase II project would expand the work to develop ASRs for Rift Valley fever, Sand Fly fever-Toscana, Crimean-Congo fever, Central European Tick-borne encephalitis and Chikungunya viruses in blood/sera from clinically ill patients.

ABOUT CALBIOTECH: Calbiotech is a worldwide provider of Immunoassay products and services. The company offers ELISA, lumELISA(TM) (Ultra-Sensitive Chemiluminescent ELISA) and Radioimmunoassay (RIA) products, as well as preclinical testing services. Calbiotech's product line includes: Endocrine, Steroid, Fertility, Cancer, Thyroid and Cardiac, Infectious
'/>"/>

SOURCE Calbiotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioNanomatrix Awarded Supplemental Funding to Accelerate Commercialization of Innovative Single-Molecule Analyzer
2. Novavax Awarded NIH Grant for Respiratory Syncytial Virus (RSV) Vaccine Program
3. Medicago awarded contract by the U.S. Army to explore applications of its plant-based technology in renewable energy
4. NeoStem, Inc. Awarded NIH Research and Research Infrastructure Grand Opportunities Grant
5. Morphotek(R), Inc. Awarded Funding to Develop Therapeutic Antibodies Against Potential Biowarfare Toxins
6. Antigen Discovery, Inc. Awarded Grant for Chlamydia Vaccine Development
7. Avaxia Biologics Awarded Phase I SBIR Grant to Develop Antibody Therapeutic for Oral Mucositis
8. Genomas Awarded $1.4 Million NIH SBIR Grant to Develop MRI+DNA Guided Biomarker System for Mental Illness
9. Hanson Technologies, Inc. Awarded Patent for its Advanced Food Pathogen Detection System
10. Masimo Radical-7(R) and Rad-57(R) Pulse CO-Oximeters(TM) Awarded Airworthiness Release Certification by the United States Army
11. 6 NTU projects awarded NRF grants

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...mbassador to also Visit Detroit , ...vid Appia, French Ambassador for International Inv...nce Agency, , , , ,What: Ambassador Appia is avai...iness initiatives adopted by France to further dev...for innovation and development., , ,When: Availabl...
(Date:11/24/2009)...ewswire-FirstCall/--Sigma-AldrichCorporation(Nasda...nTuesday,December1stat1:45PMGMTinLondon,7:45AMUS/C...overtheInternetavailableat http://inve s tor.si..."icontoaccessthisfile. ,, AboutSigma-Aldrich:...ogycompany.Itschemicalandbiochemicalproductsandkit...
(Date:11/24/2009)...ewswire-Asia/--ShanghaiBiolaxyannouncedthe,Chinese...he,investigationalnewdrugapplication(IND)foritsora...ationtotreatdiabetes.ThisIND,approvalallowsBiolaxy...etesisadisordercharacteristicofhighbloodglucoseand...ultinseveremicro-and,macro-vasculardiseases,lossof...
(Date:11/24/2009)...RNewswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: SH...oday,announcedthatithassubmittedaMAAtotheEuropeanM...zymereplacementtherapyindevelopment,forthetreatmen...licationforvelaglucerasealfathathasbeensubmitted,w... , Basedonaglobalsupplyshortageofthecurrently...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
... Aug. 14 GeoVax Labs, Inc. (OTC,Bulletin Board: G..."Company"), today announced its financial results ... ended June 30, 2007. Operating Results for the Q... net loss of $1,333,126 for the three months,ended... for the same period,in 2006. For the six months e...
...eb., Aug. 14 Transgenomic, Inc. (the,"Company") (...l results for,the quarter ended June 30, 2007. The...tables that follow. Second Quarter 2007 The Comp... per share,for the second quarter of 2007 as compa...re for the second quarter of 2006. The 2007 net pr...
..., Md., Aug. 14 Martek Biosciences,Corporation ann...ts third,quarter of fiscal 2007 on September 5, 20...me (EDT). Following the release, at 4:45 p.m. EDT ...results of its third quarter of,fiscal 2007 with i... one,hour in duration. The conference call will al...
Other Biology Technology:GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 2GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 3GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 4GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 5GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 6Transgenomic, Inc. Reports Second Quarter 2007 Results 2Transgenomic, Inc. Reports Second Quarter 2007 Results 3Transgenomic, Inc. Reports Second Quarter 2007 Results 4Transgenomic, Inc. Reports Second Quarter 2007 Results 5Transgenomic, Inc. Reports Second Quarter 2007 Results 6Transgenomic, Inc. Reports Second Quarter 2007 Results 7Transgenomic, Inc. Reports Second Quarter 2007 Results 8Martek to Announce Third Quarter 2007 Results on September 5, 2007 2
(Date:11/24/2009)...ege of Medical Toxicology (ACMT) have signed an ag...Journal of Medical Toxicology (JMT), the official... was previously published by the University of Pen...cology , an international, peer-reviewed journal, ... of medical toxicology. The quarterly journal foc...
(Date:11/24/2009)...009) New research on bacterial communities throug...dictable temporal patterns, suggesting that scient...nitoring climate change in the polar regions. The ...the National Academy of Sciences Early Edition, s...shifted synchronously over time, correlating with ...
(Date:11/23/2009)... 23, 2009 Applied mathematicians dissected the mo..., a characteristic long leaf with a saddle-like ar...edges. The simple cause of the lily,s fan-like sha... differential growthwas revealed by using an equal...Haiyi Liang, a postdoctoral student at Harvard,s S...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2The cause behind the characteristic shape of a long leaf revealed 2Retail Medical Clinics Offer Quality Care 3A Study 55763 1Retail Medical Clinics Offer Quality Care 3A Study 55763 2Retail Medical Clinics Offer Quality Care 3A Study 55763 3Flu Season Preparation Comes Early 55758 1Flu Season Preparation Comes Early 55758 2Flu Season Preparation Comes Early 55758 3Flu Season Preparation Comes Early 55758 4Shrinking Bylot Island glaciers tell story of climate change 9745 1Shrinking Bylot Island glaciers tell story of climate change 9745 2Shrinking Bylot Island glaciers tell story of climate change 9745 3Shrinking Bylot Island glaciers tell story of climate change 9745 4
... to live longer if their intake of calories is res...flies, just the smell of food can have a negative ...ecades that restricted dietary intake can increase...hat causes this is not understood. Short-lived org..., are studied to help unravel this mystery, and th...
...ence for new genes involved in the development of ...d in the next issue of the journal Human Molecular...n 4,000 volunteers. , Several genes were found...ease, the most interesting gene being ‘GALP?which ...in cells, a hallmark of Alzheimer’s disease. , ...
...ek with the first collections of cancer tissue tak...sue Bank. , The Tissue Bank is the first of its ki... diversified collection of ethically consented and...he cause, progression and potential treatment for ...mpbell AO, Director of The Wesley Research Institu...
Other Biology News:Researchers find link between food odors and lifespan in fruit flies 2Researchers find link between food odors and lifespan in fruit flies 3Researchers find link between food odors and lifespan in fruit flies 4Researchers find link between food odors and lifespan in fruit flies 5Study examines genetic risk factors for Alzheimer's disease 2Cure for cancer one step closer 2
Mouse Anti-IgG2 (Fc, gamma-2 epitope) Monoclonal Antibody, Unconjugated, Clone 52G1 from Meridian Life Science, Inc.
Orange G Loading Buffer from MBL International
Rabbit Anti-Bovine Xanthine Oxidase, Buttermilk Polyclonal Antibody, Unconjugated from Meridian Life Science, Inc.
...out ammonium sulfate are compatible with thermosta...d AmpliThem™™ DNA polymerases. You can s...s in one experiment by adding your own enzyme, tem...with the kit. This capability is made possible by ...
Biology Products: